Author
Listed:
- Ana Y. Simão
(Centro de Investigação em Ciências da Saúde (CICS-UBI), Universidade da Beira Interior, 6200-506 Covilha, Portugal
Laboratório de Fármaco-Toxicologia, UBIMedical, Universidade da Beira Interior, 6200-284 Covilha, Portugal)
- Mónica Antunes
(Centro de Investigação em Ciências da Saúde (CICS-UBI), Universidade da Beira Interior, 6200-506 Covilha, Portugal
Serviço de Química e Toxicologia Forenses, Instituto Nacional de Medicina Legal e Ciências Forenses, Delegação do Sul, 1150-219 Lisboa, Portugal)
- Emanuel Cabral
(Centro de Investigação em Ciências da Saúde (CICS-UBI), Universidade da Beira Interior, 6200-506 Covilha, Portugal
These authors contributed equally to this work.)
- Patrik Oliveira
(Centro de Investigação em Ciências da Saúde (CICS-UBI), Universidade da Beira Interior, 6200-506 Covilha, Portugal
These authors contributed equally to this work.)
- Luana M. Rosendo
(Centro de Investigação em Ciências da Saúde (CICS-UBI), Universidade da Beira Interior, 6200-506 Covilha, Portugal
These authors contributed equally to this work.)
- Ana Teresa Brinca
(Centro de Investigação em Ciências da Saúde (CICS-UBI), Universidade da Beira Interior, 6200-506 Covilha, Portugal
These authors contributed equally to this work.)
- Estefânia Alves
(Centro de Investigação em Ciências da Saúde (CICS-UBI), Universidade da Beira Interior, 6200-506 Covilha, Portugal
These authors contributed equally to this work.)
- Hernâni Marques
(Centro de Investigação em Ciências da Saúde (CICS-UBI), Universidade da Beira Interior, 6200-506 Covilha, Portugal
Laboratório de Fármaco-Toxicologia, UBIMedical, Universidade da Beira Interior, 6200-284 Covilha, Portugal
These authors contributed equally to this work.)
- Tiago Rosado
(Centro de Investigação em Ciências da Saúde (CICS-UBI), Universidade da Beira Interior, 6200-506 Covilha, Portugal
Laboratório de Fármaco-Toxicologia, UBIMedical, Universidade da Beira Interior, 6200-284 Covilha, Portugal)
- Luís A. Passarinha
(Centro de Investigação em Ciências da Saúde (CICS-UBI), Universidade da Beira Interior, 6200-506 Covilha, Portugal
UCIBIO—Applied Molecular Biosciences Unit, Departamento de Química, NOVA School of Science and Technology, Universidade NOVA, 2829-516 Caparica, Portugal
Associate Laboratory i4HB-Institute for Health and Bioeconomy, NOVA School of Science and Technology, Universidade NOVA, 2819-516 Caparica, Portugal)
- Maristela Andraus
(Chromatox/Dasa Laboratory Ltda. Sumaré, São Paulo 01259-000, Brazil)
- Mário Barroso
(Serviço de Química e Toxicologia Forenses, Instituto Nacional de Medicina Legal e Ciências Forenses, Delegação do Sul, 1150-219 Lisboa, Portugal)
- Eugenia Gallardo
(Centro de Investigação em Ciências da Saúde (CICS-UBI), Universidade da Beira Interior, 6200-506 Covilha, Portugal
Laboratório de Fármaco-Toxicologia, UBIMedical, Universidade da Beira Interior, 6200-284 Covilha, Portugal)
Abstract
The emergence of new psychoactive substances has earned a great deal of attention, and several reports of acute poisoning and deaths have been issued involving, for instance, synthetic opiates. In recent years, there have been profound alterations in the legislation concerning consumption, marketing, and synthesis of these compounds; rapid alert systems have also been subject to changes, and new substances and new markets, mainly through the internet, have appeared. Their effects and how they originate in consumers are still mostly unknown, primarily in what concerns chronic toxicity. This review intends to provide a detailed description of these substances from the point of view of consumption, toxicokinetics, and health consequences, including case reports on intoxications in order to help researchers and public health agents working daily in this area.
Suggested Citation
Ana Y. Simão & Mónica Antunes & Emanuel Cabral & Patrik Oliveira & Luana M. Rosendo & Ana Teresa Brinca & Estefânia Alves & Hernâni Marques & Tiago Rosado & Luís A. Passarinha & Maristela Andraus & Má, 2022.
"An Update on the Implications of New Psychoactive Substances in Public Health,"
IJERPH, MDPI, vol. 19(8), pages 1-42, April.
Handle:
RePEc:gam:jijerp:v:19:y:2022:i:8:p:4869-:d:795668
Download full text from publisher
References listed on IDEAS
- Maria Rosaria Varì & Giulio Mannocchi & Roberta Tittarelli & Laura Leondina Campanozzi & Giulio Nittari & Alessandro Feola & Federica Umani Ronchi & Giovanna Ricci, 2020.
"New Psychoactive Substances: Evolution in the Exchange of Information and Innovative Legal Responses in the European Union,"
IJERPH, MDPI, vol. 17(22), pages 1-15, November.
- Barbara Lovrecic & Mercedes Lovrecic & Branko Gabrovec & Marco Carli & Matteo Pacini & Angelo G. I. Maremmani & Icro Maremmani, 2019.
"Non-Medical Use of Novel Synthetic Opioids: A New Challenge to Public Health,"
IJERPH, MDPI, vol. 16(2), pages 1-21, January.
Full references (including those not matched with items on IDEAS)
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2022:i:8:p:4869-:d:795668. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.